Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

Most Recent Articles by Andrea S. Blevins Primeau, PhD, MBA

<sup>99m</sup>Tc-MIBI SPECT/CT Differentiates Between Benign, Malignant Kidney Tumors

99mTc-MIBI SPECT/CT Differentiates Between Benign, Malignant Kidney Tumors

By

Study results suggest that 99mTc-MIBI SPECT/CT use can improve the differentiation between benign and malignant kidney tumors.

Cancer-specific Reference Values Established for PROMIS Domains

Cancer-specific Reference Values Established for PROMIS Domains

By

This study's information can inform policy issues, particularly the collection of patient-reported outcome data and its use in clinical practice.

Lenalidomide Prolongs PFS Among Elderly Patients With DLBCL

Lenalidomide Prolongs PFS Among Elderly Patients With DLBCL

By

Data suggest that lenalidomide maintenance for 24 months can prolong PFS among elderly patients with DLBCL, but does not improve overall survival.

PSA Density More Accurate Than PSA for Predicting Prostate Cancer

PSA Density More Accurate Than PSA for Predicting Prostate Cancer

By

Study findings suggest that PSA density has a better accuracy for detecting prostate cancer compared with PSA higher than 4 ng/mL.

USPSTF Releases Draft PSA Screening Recommendation Update

USPSTF Releases Draft PSA Screening Recommendation Update

By

The change was initiated by additional data demonstrating a decreased mortality risk associated with PSA screening.

More Articles by Andrea S. Blevins Primeau, PhD, MBA

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters